These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 2404085)

  • 21. Interactions of nifedipine and diltiazem with muscle relaxants and reversal of neuromuscular blockade with edrophonium and neostigmine.
    Wali FA
    J Pharmacol; 1986; 17(3):244-53. PubMed ID: 3795969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of the reversal time of competitive neuromuscular block by anticholinesterases.
    Beemer GH; Bjorksten AR; Dawson PJ; Dawson RJ; Heenan PJ; Robertson BA
    Br J Anaesth; 1991 Apr; 66(4):469-75. PubMed ID: 2025474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuromuscular blockade, reversal agent use, and operating room time: retrospective analysis of US inpatient surgeries.
    Zhang B; Hepner DL; Tran MH; Friedman M; Korn JR; Menzin J
    Curr Med Res Opin; 2009 Apr; 25(4):943-50. PubMed ID: 19257799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Potentiation of nondepolarizing muscle relaxants by nifedipine iv in inhalation anesthesia].
    Jelen-Esselborn S; Blobner M
    Anaesthesist; 1990 Mar; 39(3):173-8. PubMed ID: 1970460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Edrophonium priming alters the course of neuromuscular recovery from a pipecuronium neuromuscular blockade.
    Naguib M; Abdulatif M
    Can J Anaesth; 1991 Sep; 38(6):722-7. PubMed ID: 1655299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium.
    Carroll MT; Mirakhur RK; Lowry D; Glover P; Kerr CJ
    Anaesthesia; 1998 Aug; 53(8):744-8. PubMed ID: 9797517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors predicting atracurium reversal time.
    Kirkegaard-Nielsen H; Severinsen IK; Pedersen HS; Lindholm P
    Acta Anaesthesiol Scand; 1999 Sep; 43(8):834-41. PubMed ID: 10492412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuromuscular and cardiovascular effects of atracurium during nitrous oxide-fentanyl and nitrous oxide-isoflurane anaesthesia.
    Rupp SM; Fahey MR; Miller RD
    Br J Anaesth; 1983; 55 Suppl 1():67S-70S. PubMed ID: 6688020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of halothane and enflurane on the reversibility of an Org NC45 neuromuscular blockade in cats.
    Booij LH; Crul JF; van der Pol F
    Anasth Intensivther Notfallmed; 1982 Apr; 17(2):78-80. PubMed ID: 6124173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Edrophonium: duration of action and atropine requirement in humans during halothane anesthesia.
    Cronnelly R; Morris RB; Miller RD
    Anesthesiology; 1982 Oct; 57(4):261-6. PubMed ID: 7125261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of edrophonium and neostigmine when antagonizing d-tubocurarine neuromuscular blockade in man.
    Morris RB; Cronnelly R; Miller RD; Stanski DR; Fahey MR
    Anesthesiology; 1981 May; 54(5):399-401. PubMed ID: 7224209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia.
    Larijani GE; Gratz I; Minassian SS; Hughes DL; Afshar M; Karayannis BN
    Pharmacotherapy; 1992; 12(4):278-82. PubMed ID: 1355599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Edrophonium and neostigmine for reversal of the neuromuscular blocking effect of vecuronium.
    Engbaek J; Ording H; Ostergaard D; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1985 Jul; 29(5):544-6. PubMed ID: 2863917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neostigmine-based reversal of intermediate acting neuromuscular blocking agents to prevent postoperative residual paralysis: A systematic review.
    Tajaate N; Schreiber JU; Fuchs-Buder T; Jelting Y; Kranke P
    Eur J Anaesthesiol; 2018 Mar; 35(3):184-192. PubMed ID: 29189420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrio-ventricular Block Following Neostigmine-Glycopyrrolate Reversal in Non-heart Transplant Patients: Case Report.
    Nkemngu NJ; Tochie JN
    Anesth Prog; 2018; 65(3):187-191. PubMed ID: 30235426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect on heart rate of neuromuscular blockade reversal by pyridostigmine.
    Long G; Marsh HM
    Anaesth Intensive Care; 1981 May; 9(2):144-6. PubMed ID: 7258611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atropine methylbromide and glycopyrrolate. A comparative study during reversal of neuromuscular block.
    Dworacek B; Rupreht J; Bode A; Walhout MJ
    Acta Anaesthesiol Belg; 1987; 38(2):147-52. PubMed ID: 3661106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.
    Reilly CS; Nimmo WS
    Drugs; 1987 Jul; 34(1):98-135. PubMed ID: 3308413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
    Naguib M; Abdulatif M; al-Ghamdi A
    Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-response curves for edrophonium, neostigmine, and pyridostigmine after pancuronium and d-tubocurarine.
    Donati F; McCarroll SM; Antzaka C; McCready D; Bevan DR
    Anesthesiology; 1987 Apr; 66(4):471-6. PubMed ID: 3565812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.